Company / Operating Income per Share
FENNEC PHARMACEUTICALS INC. Operating Income per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.09
FY2025
5-year range
-$0.86 / $0.09
FY2021-FY2025
Trend
+119.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 10 years, ranging from $-0.86 in FY2023 to $0.09 in FY2025.
Based on SEC 10-K filings.
0.09 in FY2025.
Improved from $-0.86 to $0.09 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 119.7% year-over-year.
- Lowest operating income per share in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.09 | +119.7% |
| FY2024 | -$0.47 | +44.9% |
| FY2023 | -$0.86 | -24.6% |
| FY2021 | -$0.69 | -31.5% |
| FY2019 | -$0.52 | -38.6% |
| FY2018 | -$0.38 | -79.4% |
| FY2017 | -$0.21 | -21.8% |
| FY2016 | -$0.17 | +36.4% |
| FY2015 | -$0.27 | -36.7% |
| FY2014 | -$0.20 | -38.1% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026